These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27922669)

  • 1. Upregulation of SMAD4 by MZF1 inhibits migration of human gastric cancer cells.
    Lee JH; Kim SS; Lee HS; Hong S; Rajasekaran N; Wang LH; Choi JS; Shin YK
    Int J Oncol; 2017 Jan; 50(1):272-282. PubMed ID: 27922669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA-337-3p inhibits gastric cancer progression through repressing myeloid zinc finger 1-facilitated expression of matrix metalloproteinase 14.
    Zheng L; Jiao W; Mei H; Song H; Li D; Xiang X; Chen Y; Yang F; Li H; Huang K; Tong Q
    Oncotarget; 2016 Jun; 7(26):40314-40328. PubMed ID: 27259238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription Factor Myeloid Zinc-Finger 1 Suppresses Human Gastric Carcinogenesis by Interacting with Metallothionein 2A.
    Lin S; Wang X; Pan Y; Tian R; Lin B; Jiang G; Chen K; He Y; Zhang L; Zhai W; Jin P; Yang L; Li G; Wu Y; Hu J; Gong W; Chang Z; Sheng JQ; Lu Y; Wang JM; Huang J
    Clin Cancer Res; 2019 Feb; 25(3):1050-1062. PubMed ID: 30301827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid Zinc Finger 1 (MZF1) Maintains the Mesenchymal Phenotype by Down-regulating IGF1R/p38 MAPK/ERα Signaling Pathway in High-level MZF1-expressing TNBC cells.
    Yue CH; Liu JY; Chi CS; Hu CW; Tan KT; Huang FM; Pan YR; Lin KI; Lee CJ
    Anticancer Res; 2019 Aug; 39(8):4149-4164. PubMed ID: 31366500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of myeloid zinc finger 1 suppresses matrix metalloproteinase-2 expression and reduces invasiveness of SiHa human cervical cancer cells.
    Tsai SJ; Hwang JM; Hsieh SC; Ying TH; Hsieh YH
    Biochem Biophys Res Commun; 2012 Aug; 425(2):462-7. PubMed ID: 22846578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphoma.
    Vishwamitra D; Curry CV; Alkan S; Song YH; Gallick GE; Kaseb AO; Shi P; Amin HM
    Mol Cancer; 2015 Feb; 14():53. PubMed ID: 25884514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer.
    Mudduluru G; Vajkoczy P; Allgayer H
    Mol Cancer Res; 2010 Feb; 8(2):159-69. PubMed ID: 20145042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MZF1 possesses a repressively regulatory function in ERCC1 expression.
    Yan QW; Reed E; Zhong XS; Thornton K; Guo Y; Yu JJ
    Biochem Pharmacol; 2006 Mar; 71(6):761-71. PubMed ID: 16426580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MZF1 Transcriptionally Activated MicroRNA-328-3p Suppresses the Malignancy of Stomach Adenocarcinoma via Inhibiting CD44.
    Qi Z; Wang J; Li Y; Xu Y
    J Immunol Res; 2022; 2022():5819295. PubMed ID: 35669102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation promotes paired box 2 expression via myeloid zinc finger 1 in endometrial cancer.
    Jia N; Wang J; Li Q; Tao X; Chang K; Hua K; Yu Y; Wong KK; Feng W
    Oncotarget; 2016 Dec; 7(51):84785-84797. PubMed ID: 27764784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor antigen PRAME is up-regulated by MZF1 in cooperation with DNA hypomethylation in melanoma cells.
    Lee YK; Park UH; Kim EJ; Hwang JT; Jeong JC; Um SJ
    Cancer Lett; 2017 Sep; 403():144-151. PubMed ID: 28634046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts.
    Le Mée S; Fromigué O; Marie PJ
    Exp Cell Res; 2005 Jan; 302(1):129-42. PubMed ID: 15541732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression.
    Wang LH; Kim SH; Lee JH; Choi YL; Kim YC; Park TS; Hong YC; Wu CF; Shin YK
    Clin Cancer Res; 2007 Jan; 13(1):102-10. PubMed ID: 17200344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-558 promotes gastric cancer progression through attenuating Smad4-mediated repression of heparanase expression.
    Zheng L; Jiao W; Song H; Qu H; Li D; Mei H; Chen Y; Yang F; Li H; Huang K; Tong Q
    Cell Death Dis; 2016 Sep; 7(9):e2382. PubMed ID: 27685626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression.
    Fang E; Wang X; Wang J; Hu A; Song H; Yang F; Li D; Xiao W; Chen Y; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
    Theranostics; 2020; 10(4):1555-1571. PubMed ID: 32042322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer.
    Yu J; Liang QY; Wang J; Cheng Y; Wang S; Poon TC; Go MY; Tao Q; Chang Z; Sung JJ
    Oncogene; 2013 Jan; 32(3):307-17. PubMed ID: 22370639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid zinc finger 1 protein is a key transcription stimulating factor of PYROXD2 promoter.
    Liu H; Jiang X; Wang T; Yu F; Wang X; Chen J; Xie X; Fan H
    Oncol Rep; 2017 Nov; 38(5):3245-3253. PubMed ID: 29048625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of MZF1/c-MYC Axis by Cantharidin Impairs Cell Proliferation in Glioblastoma.
    Wang CH; Wu HC; Hsu CW; Chang YW; Ko CY; Hsu TI; Chuang JY; Tseng TH; Wang SM
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF1α-dependent upregulation of ATAD2 promotes proliferation and migration of stomach cancer cells in response to hypoxia.
    Nayak A; Roy AD; Rout N; Singh SP; Bhattacharyya A; Roychowdhury A
    Biochem Biophys Res Commun; 2020 Mar; 523(4):916-923. PubMed ID: 31959473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of Smad4 and Smad7 expression in surgically resected samples of gastric adenocarcinoma and their correlation with clinicopathological parameters and patient survival.
    Zizi-Sermpetzoglou A; Myoteri D; Arkoumani E; Voultsos M; Marinis A
    J BUON; 2014; 19(1):221-7. PubMed ID: 24659668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.